298 related articles for article (PubMed ID: 20016535)
21. [Towards cure for all children with acute lymphoblastic leukemia?].
Baruchel A; Leblanc T; Auclerc MF; Schaison G; Leverger G
Bull Acad Natl Med; 2009 Oct; 193(7):1509-17. PubMed ID: 20669632
[TBL] [Abstract][Full Text] [Related]
22. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
[No Abstract] [Full Text] [Related]
23. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
Conter V; Aricò M; Basso G; Biondi A; Barisone E; Messina C; Parasole R; De Rossi G; Locatelli F; Pession A; Santoro N; Micalizzi C; Citterio M; Rizzari C; Silvestri D; Rondelli R; Lo Nigro L; Ziino O; Testi AM; Masera G; Valsecchi MG;
Leukemia; 2010 Feb; 24(2):255-64. PubMed ID: 20016536
[TBL] [Abstract][Full Text] [Related]
24. Testicular relapse in childhood acute lymphoblastic leukemia: the challenges and lessons.
Kulkarni KP; Marwaha RK; Trehan A; Bansal D
Indian J Cancer; 2010; 47(2):134-8. PubMed ID: 20448374
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
[TBL] [Abstract][Full Text] [Related]
27. Late relapse in a case of childhood acute lymphoblastic leukemia.
Lodha R; Jain Y; Pemde H; Bhargava M; Arya LS
Indian Pediatr; 1998 Mar; 35(3):281-3. PubMed ID: 9707888
[No Abstract] [Full Text] [Related]
28. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
30. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia.
Tsurusawa M; Shimomura Y; Asami K; Kikuta A; Watanabe A; Horikoshi Y; Matsushita T; Kanegane H; Ohta S; Iwai A; Mugishima H; Koizumi S;
Leukemia; 2010 Feb; 24(2):335-44. PubMed ID: 20016539
[TBL] [Abstract][Full Text] [Related]
32. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
Coustan-Smith E; Gajjar A; Hijiya N; Razzouk BI; Ribeiro RC; Rivera GK; Rubnitz JE; Sandlund JT; Andreansky M; Hancock ML; Pui CH; Campana D
Leukemia; 2004 Mar; 18(3):499-504. PubMed ID: 14981525
[TBL] [Abstract][Full Text] [Related]
34. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
[TBL] [Abstract][Full Text] [Related]
35. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.
Yeoh AE; Ariffin H; Chai EL; Kwok CS; Chan YH; Ponnudurai K; Campana D; Tan PL; Chan MY; Kham SK; Chong LA; Tan AM; Lin HP; Quah TC
J Clin Oncol; 2012 Jul; 30(19):2384-92. PubMed ID: 22614971
[TBL] [Abstract][Full Text] [Related]
36. Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
Renard M; Suciu S; Bertrand Y; Uyttebroeck A; Ferster A; van der Werff Ten Bosch J; Mazingue F; Plouvier E; Robert A; Boutard P; Millot F; Munzer M; Mechinaud F; Lescoeur B; Baila L; Vandecruys E; Benoit Y; Philippet P;
Pediatr Blood Cancer; 2011 Jul; 57(1):119-25. PubMed ID: 21412967
[TBL] [Abstract][Full Text] [Related]
37. [Recurrence of acute lymphoblastic leukemia after 12 years of complete remission].
Seidl P; Sahm S; Kornhuber B
Klin Padiatr; 1988; 200(6):448-50. PubMed ID: 3236749
[TBL] [Abstract][Full Text] [Related]
38. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
Radwańska U
Pediatr Pol; 1988 Nov; 63(11):689-92. PubMed ID: 3253654
[No Abstract] [Full Text] [Related]
39. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
40. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
